Drug Type AAV based gene therapy |
Synonyms |
Target |
Action stimulants |
Mechanism GDNF stimulants(Glial cell line-derived neurotrophic factors stimulants), Gene transference, Neurons stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Phase 2 | - | - | |
Parkinson Disease | Phase 2 | - | - | |
Parkinson Disease | Phase 2 | - | - | |
Parkinson Disease | Phase 2 | - | - | |
Multiple System Atrophy | Preclinical | United States | 01 Apr 2021 |